ATE152735T1 - Inhibitorvariante der menschlichen protease vom kunitz-typ - Google Patents

Inhibitorvariante der menschlichen protease vom kunitz-typ

Info

Publication number
ATE152735T1
ATE152735T1 AT93902104T AT93902104T ATE152735T1 AT E152735 T1 ATE152735 T1 AT E152735T1 AT 93902104 T AT93902104 T AT 93902104T AT 93902104 T AT93902104 T AT 93902104T AT E152735 T1 ATE152735 T1 AT E152735T1
Authority
AT
Austria
Prior art keywords
amino acid
kunitz
variant
naturally occurring
acid residues
Prior art date
Application number
AT93902104T
Other languages
English (en)
Inventor
Fanny Norris
Kjeld Norris
Rn S Ren Erik Bj
Lars Christian Petersen
Ole Hvilsted Olsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE152735T1 publication Critical patent/ATE152735T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
  • Saccharide Compounds (AREA)
AT93902104T 1992-01-07 1993-01-07 Inhibitorvariante der menschlichen protease vom kunitz-typ ATE152735T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK9200004 1992-01-07

Publications (1)

Publication Number Publication Date
ATE152735T1 true ATE152735T1 (de) 1997-05-15

Family

ID=8153774

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902104T ATE152735T1 (de) 1992-01-07 1993-01-07 Inhibitorvariante der menschlichen protease vom kunitz-typ

Country Status (15)

Country Link
EP (1) EP0621870B1 (de)
JP (1) JPH07506241A (de)
AT (1) ATE152735T1 (de)
AU (1) AU675925B2 (de)
CA (1) CA2127250A1 (de)
CZ (1) CZ164594A3 (de)
DE (1) DE69310499D1 (de)
FI (1) FI943232A7 (de)
HU (1) HUT70294A (de)
IL (1) IL104326A0 (de)
NO (1) NO942551L (de)
NZ (1) NZ246568A (de)
RU (1) RU94045952A (de)
WO (1) WO1993014120A1 (de)
ZA (1) ZA9397B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2229236T3 (es) 1994-01-11 2005-04-16 Dyax Corporation Inhibidores de la plasmina humana derivados de los dominios de kunitz.
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
PT739355E (pt) * 1994-01-11 2005-01-31 Dyax Corp Proteinas de 'dominio de kunitz' inibidoras de calicreina e seus analogos
US5795954A (en) * 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins
US5589359A (en) * 1994-08-05 1996-12-31 Chiron Corporation Chimeric proteins
JP3779728B2 (ja) * 1994-08-05 2006-05-31 カイロン コーポレイション 組織因子活性インヒビターの産生
JPH11504938A (ja) * 1995-05-08 1999-05-11 サイオス インク． クニッツ型プロテアーゼ阻害因子
ZA963619B (en) 1995-05-08 1996-11-22 Scios Inc Protease inhibitor peptides
US5780265A (en) * 1995-06-05 1998-07-14 Genentech, Inc. Kunitz type plasma kallikrein inhibitors
US5786328A (en) * 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
US6242414B1 (en) 1995-06-07 2001-06-05 Chiron Corporation Regulation of cytokine synthesis and release
IL126115A (en) 1996-03-11 2007-03-08 Aerovance Inc Significantly purified protein with suppressive activity for sirin protease and its pharmaceutical preparations
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
WO2003103475A2 (en) 2002-06-07 2003-12-18 Dyax Corp. Prevention and reduction of blood loss
JP2005537006A (ja) 2002-08-28 2005-12-08 ダイアックス、コープ 臓器及び組織の保存方法
US6989369B2 (en) 2003-02-07 2006-01-24 Dyax Corp. Kunitz domain peptides
PT1663281E (pt) 2003-08-29 2014-03-17 Dyax Corp Inibidores de proteases poli-peguilados
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
ES2431526T3 (es) * 2005-12-29 2013-11-26 The Regents Of The University Of California Office Of Technology Transfer Procedimientos y composiciones relacionadas con el dominio Kunitz I mutante de TFPI-2
US7276480B1 (en) 2005-12-30 2007-10-02 Dyax Corp. Prevention and reduction of blood loss
WO2010071894A2 (en) 2008-12-19 2010-06-24 Baxter International Inc. Tfpi inhibitors and methods of use
CA2744235A1 (en) 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
CN101798346B (zh) * 2009-02-06 2013-05-29 复旦大学 一种酵母表达的长效重组人组织因子途径抑制物
EP3459564B1 (de) 2010-01-06 2021-10-27 Takeda Pharmaceutical Company Limited Plasmakallikreinbindende proteine
AU2011227714B2 (en) 2010-03-19 2014-09-04 Takeda Pharmaceutical Company Limited TFPI inhibitors and methods of use
CA2823776A1 (en) 2011-01-06 2012-07-12 Dyax Corp. Plasma kallikrein binding proteins
WO2013141965A1 (en) 2012-03-21 2013-09-26 Baxter International Inc. Tfpi inhibitors and methods of use
AU2016366557B2 (en) 2015-12-11 2024-01-25 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
US12528880B2 (en) 2020-01-13 2026-01-20 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106833A (en) * 1987-07-23 1992-04-21 Washington University Coagulation inhibitors
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner

Also Published As

Publication number Publication date
HUT70294A (en) 1995-09-28
EP0621870A1 (de) 1994-11-02
CA2127250A1 (en) 1993-07-22
EP0621870B1 (de) 1997-05-07
IL104326A0 (en) 1993-05-13
JPH07506241A (ja) 1995-07-13
NO942551L (no) 1994-09-07
NO942551D0 (no) 1994-07-06
FI943232A0 (fi) 1994-07-06
DE69310499D1 (de) 1997-06-12
CZ164594A3 (en) 1994-12-15
HU9401992D0 (en) 1994-09-28
AU3345893A (en) 1993-08-03
ZA9397B (en) 1993-08-10
FI943232L (fi) 1994-07-06
AU675925B2 (en) 1997-02-27
NZ246568A (en) 1996-02-27
FI943232A7 (fi) 1994-07-06
RU94045952A (ru) 1996-10-10
WO1993014120A1 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
ATE152735T1 (de) Inhibitorvariante der menschlichen protease vom kunitz-typ
ATE154938T1 (de) Inhibitorvariante der menschlichen protease vom kunitz-typ
FI961886L (fi) Ihmisen Kunitz-tyyppiset proteaasi-inhibiittorit
FI943234A7 (fi) Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnos
FI943231L (fi) Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnoksia
ZA923602B (en) Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
HUT58204A (en) Magnesium-pyridoxale-5'-phosphate-glutaminate for preventing diseases originated from blood-vessel-alternations
DE69129809D1 (de) Aprotininanaloga
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
ITBZ930026A0 (it) Procedimento per la movimentazione traslatoria di componenti ed azio- natore di movimento per l'attuazione del procedimento.
NO901558D0 (no) Vasoaktive peptider.
IT1264129B1 (it) Peptidi ad attivita' immunomodulatoria derivati da frammenti di leucochinina
KR930016980U (ko) Tv의 고압조기 방전회로
ITMI922378A1 (it) Procedimento per la stabilizzazione di residui e bitumi.
KR930007725U (ko) Crt 고압 방전회로

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties